Carrier: DNA complexes containing DNA encoding anti-angiogenic p

Details Carrier: DNA complexes containing DNA encoding anti-angiogenic p Carrier: DNA complexes containing DNA encoding anti-angiogenic p

1997-12-05

2000-06-27

Campbell, Bruce R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

424450, A61K 4800

Patent

active

060807288

ABSTRACT:
Carrier complexes comprising DNA encoding an anti-angiogenic gene or peptide and optionally a further DNA encoding a tumor suppressor protein are described. When administered to a subject bearing a tumor, the complexes can inhibit growth of the tumor.

REFERENCES:
patent: 5631237 (1997-05-01), Dzau et al.
patent: 5770581 (1998-06-01), Weichselbaum et al.
patent: 5792845 (1998-08-01), O'Reilly et al.
patent: 5814618 (1998-09-01), Bujard et al.
patent: 5851999 (1998-12-01), Ullrich et al.
TE Maione et al (1991) Cancer Research 51: 2077-2083.
N Sakamoto et al (1991) Cancer Research 51: 903-906.
MS Sheikh et al (1995) Oncogene 11: 1899-1905.
TPD Fan et al (1995) Trends Pharmaceutical Sciences 16:57-66.
I Saiki et al (1990) Japanese J Cancer Research 81:668-675.
C Clapp et al (1993) Endocrinology 133: 1292-1299.
MJ Hawkins (1995) Current Opinion in Oncology 7:90-93.
Human Gene Therapy, 6:395-405 (Apr. 1995), "Systemic Gene Therapy with p53 Reduces Growth & Metastases of a Malignant Human Breast Cancer in Nude Mice" Leslie A. Lesoon-Wood et al.
Human gene Therapy 8:177-185 (Jan. 20, 1997), "Parenteral gene Therapy with p53 Inhibits Human Breast Tumors In Vivo Through a Bystander Mechanism Without Evidence of Toxicity", M. Xu et al.
Molecular Genetics & Metabolisms 63-103-109 (1998), "Gene Therapy with P53 and a Fragment of Thrombospondin I Inhibits Human Breast Cancer in Vivo", M. Xu et al.
Molecular genetics & Metabolism 64,000-000 (1998), "In Vivo Gene Therapy with a Cationic Polymer Markedly Enhances the Antitumor Activity of Antiangiogenic Genes" M. Xu et al.
Lesoon-Wood et a., Human Gene Therapy, 6:395-405 (Apr. 1995), pp. 395-405.
Weinstat-Saslow et al., Cancer Research 54:6504-6511 (1994).
Dameron et al., Science. vol. 265;1582 (1994).
O'Reilly et al., Cell, vol. 79:315, (1994).
Millauer et al., Nature, vol. 367:576, (1994).
Pasquallni et al., Nature, vol. 380:364, (1996).
Tanaka et al., Nature Medicine, vol. 3:437 (1997).
"Vectors for Gene Therapy", Chapter 12, John Wiley and Sons (1997).
O'Reilly et al., Cell, 88:277, (1997).
Calos, TIG, vol. 12:463, (1996).
Tolsma et al., The Journal of Cell Biology, vol. 122, Jul. 1993, pp. 497-510.
Goldman et al., Nature Biotechnology, 15:462, (1997).
Boussif et al., Proc. Natl. Acad. Sci., vol. 92: 7297, (1995).
Cheng, Human Gene Therapy, 7:275, (1996).
Pasqulini et al., Nature Biotechnology, 15:542, (1997).
Park et al., Proc. Am. Ass. Canc. Res., 38, No. 2291, (Mar. 1997).

Affiliated with

Also associated with

Rating

Carrier: DNA complexes containing DNA encoding anti-angiogenic p does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carrier: DNA complexes containing DNA encoding anti-angiogenic p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carrier: DNA complexes containing DNA encoding anti-angiogenic p will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1784854